<html>
<head>PUBMED IDs for SLF2</head>
<body bgcolor='#C5F0F2'><h1>SLF2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/3028777/'>Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.</a> December 1  1986<br><a href='https://pubmed.ncbi.nlm.nih.gov/2542618/'>The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.</a> January Journal of virology
  7<br><a href='https://pubmed.ncbi.nlm.nih.gov/2555554/'>The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.</a> January Journal of virology
  12<br><a href='https://pubmed.ncbi.nlm.nih.gov/1850023/'>Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R trans activator.</a> May 1  1991<br><a href='https://pubmed.ncbi.nlm.nih.gov/7975218/'>Epstein-Barr virus SM protein.</a> November 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/23609041/'>Development of episomal vectors carrying a nourseothricin-resistance marker for use in minimal media for Schizosaccharomyces pombe.</a> November 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/28379579/'>Discovery of novel heart rate-associated loci using the Exome Chip.</a> April 6  2017<br></body></html>
